ID   SK-N-BE(1)
AC   CVCL_9898
SY   SK-N-Be(1); SKNBE(1); SKNBE-1; SKNBE1
DR   Wikidata; Q54954440
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=29704;
RX   PubMed=2535691;
RX   PubMed=11507071;
RX   PubMed=24792489;
WW   http://www.cccells.org/dl/NB_Data_Sheets/SK-N-BE1_Cell_Line_Data_Sheet_COGcell_org.pdf
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Doubling time: ~4 days (PubMed=29704); 96 hours (COG).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 14,16
ST   D19S433: 12,13
ST   D21S11: 30,32.2
ST   D2S1338: 17,23
ST   D3S1358: 19
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 22,25
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0528 ! SK-N-BE(2)
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 22
//
RX   DOI=10.1007/0-306-46872-7_2;
RA   Thiele C.J.;
RT   "Neuroblastoma.";
RL   (In) Human cell culture. Vol. 1. Cancer Cell Lines part 1; Masters J.R.W., Palsson B.O. (eds.); pp.21-53; Kluwer Academic Publishers; New York (1999).
//
RX   PubMed=29704;
RA   Biedler J.L., Roffler-Tarlov S., Schachner M., Freedman L.S.;
RT   "Multiple neurotransmitter synthesis by human neuroblastoma cell lines
RT   and clones.";
RL   Cancer Res. 38:3751-3757(1978).
//
RX   PubMed=2535691;
RA   Ciccarone V., Spengler B.A., Meyers M.B., Biedler J.L., Ross R.A.;
RT   "Phenotypic diversification in human neuroblastoma cells: expression
RT   of distinct neural crest lineages.";
RL   Cancer Res. 49:219-225(1989).
//
RX   PubMed=11507071;
RA   Keshelava N., Zuo J.J., Chen P., Waidyaratne S.N., Luna M.C.,
RA   Gomer C.J., Triche T.J., Reynolds C.P.;
RT   "Loss of p53 function confers high-level multidrug resistance in
RT   neuroblastoma cell lines.";
RL   Cancer Res. 61:6185-6193(2001).
//
RX   PubMed=24792489; DOI=10.1007/s11060-014-1456-8;
RA   Farooqi A.S., Dagg R.A., Choi L.M.R., Shay J.W., Reynolds C.P.,
RA   Lau L.M.S.;
RT   "Alternative lengthening of telomeres in neuroblastoma cell lines is
RT   associated with a lack of MYCN genomic amplification and with p53
RT   pathway aberrations.";
RL   J. Neurooncol. 119:17-26(2014).
//